Corporate ActionApr 27, 2026, 04:02 PM
NTLA Commences $150M Underwritten Public Offering of Common Stock
AI Summary
Intellia Therapeutics, Inc. announced the commencement of an underwritten public offering of $150 million of its common stock. The company also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares offered. All shares in the proposed offering will be sold by Intellia, with Jefferies, Goldman Sachs & Co. LLC, and Citigroup acting as joint book-running managers.
Key Highlights
- Intellia Therapeutics commenced an underwritten public offering of $150 million of common stock.
- Underwriters have a 30-day option to purchase up to an additional 15% of shares.
- All shares in the proposed offering are to be sold by Intellia.
- Jefferies, Goldman Sachs & Co. LLC, and Citigroup are joint book-running managers.